Goldman Sachs Group Inc Scopus Bio Pharma Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 14, 2024
BUY
$0.36 - $0.74 $6,265 - $12,879
17,405 New
17,405 $7,000
Q2 2022

Aug 15, 2022
BUY
$0.36 - $0.74 $6,265 - $12,879
17,405 New
17,405 $7,000

About Scopus BioPharma Inc.

SCPS Quotes by TradingView
  • Ticker SCPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,094,300
  • Description
  • Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...
More about SCPS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email